Seeking Alpha

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical ...
KBIA

Health Department providing education and new rapid HIV/Syphilis test at Mid-Missouri PrideFest

Mid-Missouri PrideFest happens each fall. It includes a street fair, music performances, drag shows and more. Columbia/Boone County Public Health & Human Services will be at Mid-Missouri PrideFest ...
JSTOR Daily

Performance of a Dual Human Immunodeficiency Virus/Syphilis Rapid Test Compared With Conventional Serological Testing for Syphilis and Human Immunodeficiency Virus in a ...

Cornelis A. Rietmeijer, More Mungati, Peter H. Kilmarx, Beth Tippett Barr, Elizabeth Gonese, Ranmini S. Kularatne, David A. Lewis, Jeffrey D. Klausner, Luanne Rodgers ...
Pharmabiz

Mylab launches range of rapid tests for HIV, HCV and syphilis

Mylab Discovery Solutions expanded its portfolio of rapid tests for sexually transmitted diseases (STIs), namely HIV, HCV and syphilis. Among these tests, HIV 1/2 Ab and HCV Ab are rapid tests for the ...
Seeking Alpha

Chembio not quite there with HIV/Syphilis test application; shares down 13%

Thinly traded nano cap Chembio Diagnostics (CEMI-13.1%) is down on modestly higher volume, only 148K shares, on the heels of an update on its U.S. marketing application for its DPP HIV-Syphilis Assay ...